Skip to main content
BrainCited

Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (Prakriti) in healthy adults: clinical trial protocol.

H L N R Pradeep, P K Perera, P R Waratenne, N Samaranayake, W D N Dissanayake
Other Frontiers in medicine 2026
PubMed DOI PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'pmid\u003D41836921'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
Randomized Controlled Trial
Population
elderly participants with MoCA score >=24
Duration
6 weeks
Intervention
Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (Prakriti) in healthy adults: clinical trial p 120 mL twice daily for 45 days
Comparator
placebo
Primary Outcome
telomerase activity and telomere length
Effect Direction
Neutral
Risk of Bias
Low

Abstract

BACKGROUND: Aging is an irreversible process shaped by genetic and environmental factors. Beyond physical and mental decline, it involves complex biological mechanisms. Programmed theories propose aging follows a biological clock, while error theories attribute it to environmental damage. A key mechanism is telomere shortening; once critically shortened, cells enter senescence. Telomerase preserves telomeres, but its activity decreases with age. Aging also causes cognitive decline, measurable through tools like electroencephalography (EEG). STUDY DESIGN: This two-arm, double blind, placebo-controlled superiority randomized controlled trial evaluates the effects of Bacopa monnieri freeze-dried herbal decoction (BMFD) on aging and cognition. Elderly participants (MoCA ≥24) will be randomized to receive BMFD or placebo, administered as 120 mL twice daily for 45 days, with assessments at baseline, 45, and 90 days. Conducted at the Clinical Trial Center, Faculty of Indigenous Medicine, University of Colombo, the trial tests BMFD's ability to stabilize aging processes and enhance neurocognitive functions. OUTCOMES: Primary outcomes include telomerase activity and telomere length (qPCR). Secondary outcomes include neurocognitive function [validated MoCA for the Sri Lankan population], neurophysiological functions-nerve conduction test (NCT) for upper and lower limb nerves and brain electrical activity (EEG)-and assessing health-related quality of life (HRQoL) using a validated questionnaire. DISCUSSION: This trial will provide evidence on BMFD's potential to preserve telomere length, support cognitive functions, and slow aging processes. Integrating Ayurvedic principles, including constitution (Prakriti), it aims to enable early detection of cognitive decline and aging-related changes. Findings are expected to inform preventive and personalized strategies, contributing to evidence-based applications of Bacopa monnieri in healthy aging. CLINICAL TRIAL REGISTRATION: https://doi.org/10.1186/ISRCTN64126920, identifier ISRCTN64126920.

TL;DR

This trial will provide evidence on BMFD’s potential to preserve telomere length, support cognitive functions, and slow aging processes, to enable early detection of cognitive decline and aging-related changes.

Full Text

PDF
Loading PDF...

Used In Evidence Reviews

Similar Papers